Leerink Partners Downgrades CVS Health (CVS) to Market Perform

Leerink Partners analyst Michael Cherny downgraded CVS Health (NYSE: CVS) from Outperform to Market Perform with a price target of $60.00.

For an analyst ratings summary and ratings history on CVS Health click here. For more ratings news on CVS Health click here.

Shares of CVS Health closed at $67.71 yesterday.

You May Also Be Interested In

• Deutsche Bank Downgrades L'Oreal SA (OR:FP) (LRLCY) to Sell
• Wells Fargo Downgrades Ross Stores, Inc. (ROST) to Equal Weight
• Evercore ISI Downgrades Inspire Medical Systems (INSP) to In Line